In the rapidly evolving landscape of health and wellness technology, QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP)—formerly known as Predictmedix AI—is establishing itself as a leader in “Quantum-AI” synergy. The Toronto-based innovator is currently commanding the international stage, achieving a trifecta of milestones this week: a novel U.S. patent filing, a high-profile trade mission to Mexico, and national recognition on CBC News.
Quantum-Inspired Innovation: The Intellectual Property Edge
The core of QScreen AI’s value proposition lies in its fusion of quantum computing principles with classical artificial intelligence. The company recently filed a provisional patent (Application – 63/981,576) for a “System, Method, and Robotic Platform for Quantum-Inspired Multi-Objective Optimization.” Unlike traditional “one-size-fits-all” AI, QScreen’s technology utilizes probabilistic algorithms—modeled after the energy minimization seen in quantum mechanics—to solve complex logistical challenges. This system allows for real-time adjustments in high-pressure environments, such as military clinical intake or public health surges. By balancing speed, risk detection, and clinician workload under “unbreakable safety guardrails,” QScreen is effectively “future-proofing” its tech to be compatible with future quantum solvers while delivering immediate results on today’s hardware.
The Mexico Trade Mission and National Spotlight
The strategic importance of QScreen AI is being highlighted right now during Canada’s historic trade mission to Mexico (February 15–20). Dr. Rahul Kushwah, COO of QScreen AI, is currently on the ground in Mexico as part of a select group of Canadian business leaders. In a nationally televised interview with CBC News, Dr. Kushwah explained that this mission provides direct access to “institutional stakeholders and decision-makers,” bypassing traditional market barriers.
The trade mission, led by Minister Dominic LeBlanc, underscores a broader North American shift toward cross-border innovation. As meetings progress this week, Dr. Kushwah notes that Mexico’s manufacturing and automotive sectors are pumping significant capital into workplace safety. This creates a “perfect storm” of demand for QScreen’s Smarthealth AI stations, which analyze physiological data patterns to predict 19 vital parameters, including impairment and fatigue, in seconds.
Investor Perspective: Why Now?
For investors, QScreen AI represents a compelling “early-mover” opportunity in the Quantum-AI space. While many AI companies remain purely software-based, QScreen offers a tangible, hardware-agnostic solution currently being deployed in real-world scenarios.
Strategic U.S. Alliances: Through active engagement with Global Frontier Advisors L.P.—led by senior U.S. officials, including the former Director of the DoD’s Joint Artificial Intelligence Center—QScreen is tapping into the lucrative U.S. public safety and defense markets.
Scalable Revenue Model: By targeting large-scale institutional buyers in the military, corrections, and enterprise wellness sectors, the company is moving from R&D into a phase of aggressive global commercialization.
Intellectual Property Moat: The current patent filing provides a significant defensive moat, ensuring that their unique “Dual-Trigger Logic” and “Hybrid Governance” systems remain proprietary as they expand.
QScreen AI is no longer just a “predictive” company; it is an optimization engine. With the backing of the Canadian government, a robust IP portfolio, and active negotiations currently underway in the Mexican and U.S. markets, QScreen AI is proving that the future of healthcare isn’t just digital—it’s quantum-inspired.
QScreen AI is part of the delegation to the trade mission to Mexico. QScreen’s COO and Director Rahul Kushwah spoke with CBC’s Rosemary Barton to highlight Qscreen’s value proposition.
Legal Disclaimer
- General Information and Liability
This blog/article is curated by the content team of Ubika and SmallCapPower (“SCP”) and and is provided exclusively for informational purposes. No fees were received by Ubika and SmallCapPower for creation and distribution of the content. Ubika/SCP and their affiliates assume no responsibility for the accuracy, completeness, or timeliness of the information presented in this article. All content has been derived from publicly available, non-material information deemed reliable but is not guaranteed by UBika/SCP and its affiliates as to its accuracy or completeness.
Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or futures contracts in certain underlying companies mentioned in this site and in this article and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
- No Endorsement or Financial Advice
Ubika Corp / SmallCapPower and it’s afiliates (“SCP”) does not own shares or have any financial interest in QScreen AI Inc. , however, shareholders of Ubika Corp / SmallCapPower and it’s afiliates (“SCP”) also own shares of QScreen AI Inc. Certain shareholders of Ubika Corp/SmallCapPower and their affiliates may also be affiliated with QScreen AI Inc. and may hold official positions in QScreen AI Inc. SCP’s role is strictly limited to managing and distributing this Article. SCP does not provide, endorse, or imply any form of financial, legal, or investment advice, nor does it recommend or endorse the purchase or sale of securities related to QScreen AI Inc. SCP has not been paid any fees for the distribution of this content.
- Risk Disclaimer
Investing in securities, including those of QScreen AI Inc. , involves inherent risks, including the potential loss of capital. Neither SCP nor QScreen AI Inc. assumes responsibility for any direct, indirect, consequential, or incidental damages or losses incurred by individuals relying on the information provided in this newsletter.
- Forward-Looking Statements
This article/blog may contain forward-looking statements as defined by Canadian and U.S. securities laws. Such statements reflect QScreen AI Inc. ‘ current expectations and views of future events and may include terms such as “expects,” “anticipates,” “plans,” and “believes,” among others. These statements involve risks, uncertainties, and assumptions that may cause actual results to differ materially from those projected. QScreen AI Inc. does not undertake any obligation to update these forward-looking statements except as required by law. Additional details can be found in QScreen AI Inc. ‘ public filings at www.sedar.com.
- Due Diligence and Professional Advice
Readers are strongly encouraged to perform their own due diligence before making any investment decisions. This includes reviewing QScreen AI Inc. ‘ publicly available financial statements, reports, and other filings, or consulting with independent financial or legal advisors for tailored advice.
- No Offer or Solicitation
This article/blog does not constitute an offer to sell or a solicitation to buy any securities or financial instruments. Investment decisions made by individuals are their sole responsibility and should be based on their own judgment and analysis. This content is not a substitute for professional investment advice.
- Limitation of Ubika Corp., SmallCapPower (SCP) and their Affiliates Role and Responsibilities
Ubika/SCP and their affiliates involvement is limited to distributing this article/blog. The content provided in this article is based on the publicly available sources and analysis performed by Ubika/SCP content team, which is based on several assumptions that may not be accurate. Ubika/SCP and their affiliates are not liable for errors, omissions, or inaccuracies in the content or any actions taken by readers based on this information.
- Acknowledgement and Agreement
By engaging with this article/blog/site/email, you acknowledge that you have read, understood, and agreed to this legal disclaimer. You accept that reliance on the information provided is at your own risk.
